Effect of D,L‐carnitine on the response of the isolated heart of the rat to ischaemia and reperfusion: relation to mitochondrial function
Open Access
- 1 December 1989
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 98 (4) , 1319-1327
- https://doi.org/10.1111/j.1476-5381.1989.tb12680.x
Abstract
1 The effect of 100 μm (20 μg ml−1) of D,L-carnitine was studied on the isolated heart of the rat subjected to 30 min of low flow ischaemia followed by reperfusion. 2 In untreated hearts (n = 30) ischaemia produced an almost total loss of contractility (P < 0.05 compared with non-ischaemic time control) which was accompanied by an increase in resting tension of approximately 235% (P < 0.05). Ventricular arrhythmias developed during ischaemia in 100% (P < 0.05) of untreated hearts studied. Following reperfusion, untreated hearts recovered 16.3% of contractile function and demonstrated a 60% elevation in resting tension. The incidence of reperfusion-associated ventricular fibrillation was 60%. 3 Carnitine treatment produced no effect on either the contractile depression or the elevation in resting tension during ischaemia but did significantly decrease the incidence of arrythmias at the termination of ischaemia to 63.3% (n = 30, P > 0.05). In the presence of carnitine, contractile recovery at the end of reperfusion was significantly increased to 30.2% (n = 10, P < 0.05) and the elevation in resting tension was decreased to 30% (n = 10, P > 0.05). The incidence of ventricular arrhythmias during reperfusion was significantly reduced by carnitine. 4 Two populations of mitochondria, subsarcolemmal (SLM) and interfibrillar (IFM) isolated at the end of the ischaemic period exhibited an overall increase in oxidative phosphorylation rates as well as uncoupled oxygen consumption; both phenomena were more pronounced with IFM. Carnitine generally potentiated this response. A 29% and 38% inhibition in atractyloside-sensitive ADP uptake was observed in SLM and IFM, respectively, following ischaemia, which was partially prevented by carnitine. 5 After 10 min of reperfusion, adenosine diphosphate (ADP) uptake in SLM was further reduced to 55% of control whereas with IFM, uptake was not different from that seen at the end of ischaemia. Mitochondria isolated from hearts after 30 min of reperfusion revealed a significantly depressed oxidative phosphorylation as well as ADP/ATP translocase activity. These defects were partially reversed in hearts perfused with carnitine. 6 Our study demonstrates that D,L-carnitine protects the rat isolated heart against injury associated with ischaemia and reperfusion through a mechanism associated with improved mitochondrial function.This publication has 32 references indexed in Scilit:
- The Pharmacology of CarnitineAnnual Review of Pharmacology and Toxicology, 1987
- Changes in creatine phosphate, inorganic phosphate, and the purine pattern in dog hearts with time of coronary artery occlusion and effect thereon of mioflazine, a nucleoside transport inhibitorCardiovascular Research, 1986
- Metabolic and physiological differences between zero-flow and low-flow myocardial ischemia: effects of L-acetylcarnitineBasic Research in Cardiology, 1984
- Control of myocardial levels of CoA and carnitineJournal of Molecular and Cellular Cardiology, 1982
- Effects of carnitine on the ischemic arrested heartBasic Research in Cardiology, 1982
- Oxidative phosphorylation function of two mitochondrial preparations from heart: effects of ischaemia and cytochrome CBasic Research in Cardiology, 1982
- Protection of the Myocardium during Ischemic Arrest: Possible Toxicity of Carnitine in Cardioplegic Solutions*The Thoracic and Cardiovascular Surgeon, 1980
- Role of carnitine in fatty acid metabolism of normal and ischemic myocardiumAmerican Heart Journal, 1979
- Carnitine and acetyl-carnitine, natural substances endowed with interesting pharmacological properties.Life Sciences, 1978
- Protection of the ischemic dog myocardium with carnitineThe American Journal of Cardiology, 1978